Your browser doesn't support javascript.
loading
Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma.
Mair, Maximilian J; Ilhan-Mutlu, Ayseguel; Pajenda, Sahra; Kiesel, Barbara; Wöhrer, Adelheid; Widhalm, Georg; Dieckmann, Karin; Marosi, Christine; Wagner, Ludwig; Preusser, Matthias; Berghoff, Anna S.
Afiliação
  • Mair MJ; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Ilhan-Mutlu A; Christian Doppler Laboratory for Personalized Immunotherapy, Medical University of Vienna, Vienna, Austria.
  • Pajenda S; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Kiesel B; Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Wöhrer A; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Widhalm G; Department of Neurology, Division of Neuropathology and Neurochemistry, Medical University of Vienna, Vienna, Austria.
  • Dieckmann K; Department of Neurosurgery, Medical University of Vienna, Vienna, Austria.
  • Marosi C; Department of Radiation Oncology, Medical University of Vienna, Vienna, Austria.
  • Wagner L; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
  • Preusser M; Department of Medicine III, Medical University of Vienna, Vienna, Austria.
  • Berghoff AS; Department of Medicine I, Division of Oncology, Medical University of Vienna, Vienna, Austria.
Cancer Immunol Immunother ; 70(12): 3643-3650, 2021 Dec.
Article em En | MEDLINE | ID: mdl-33956203
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Bevacizumab / Glioma / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antígeno B7-H1 / Bevacizumab / Glioma / Recidiva Local de Neoplasia Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article